Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Citations for PubMed (Select 24625106)

1.

Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines.

Van Horn KS, Burda WN, Fleeman R, Shaw LN, Manetsch R.

J Med Chem. 2014 Apr 10;57(7):3075-93. doi: 10.1021/jm500039e. Epub 2014 Mar 31.

PMID:
24625106
2.

Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.

Van Horn KS, Zhu X, Pandharkar T, Yang S, Vesely B, Vanaerschot M, Dujardin JC, Rijal S, Kyle DE, Wang MZ, Werbovetz KA, Manetsch R.

J Med Chem. 2014 Jun 26;57(12):5141-56. doi: 10.1021/jm5000408. Epub 2014 Jun 17.

PMID:
24874647
3.

Relationship between structure and antibacterial activity of lipophilic N-acyldiamines.

de Almeida CG, Garbois GD, Amaral LM, Diniz CC, Le Hyaric M.

Biomed Pharmacother. 2010 Apr;64(4):287-90. doi: 10.1016/j.biopha.2009.09.013. Epub 2009 Nov 5.

PMID:
19942397
4.

SAR refinement of antileishmanial N2,N4-disubstituted quinazoline-2,4-diamines.

Zhu X, Van Horn KS, Barber MM, Yang S, Wang MZ, Manetsch R, Werbovetz KA.

Bioorg Med Chem. 2015 Feb 18. pii: S0968-0896(15)00114-5. doi: 10.1016/j.bmc.2015.02.020. [Epub ahead of print]

PMID:
25749014
5.

Systemic antibacterial activity of novel synthetic cyclic peptides.

Dartois V, Sanchez-Quesada J, Cabezas E, Chi E, Dubbelde C, Dunn C, Granja J, Gritzen C, Weinberger D, Ghadiri MR, Parr TR Jr.

Antimicrob Agents Chemother. 2005 Aug;49(8):3302-10.

6.

Discovery of a novel and potent class of FabI-directed antibacterial agents.

Payne DJ, Miller WH, Berry V, Brosky J, Burgess WJ, Chen E, DeWolf Jr WE Jr, Fosberry AP, Greenwood R, Head MS, Heerding DA, Janson CA, Jaworski DD, Keller PM, Manley PJ, Moore TD, Newlander KA, Pearson S, Polizzi BJ, Qiu X, Rittenhouse SF, Slater-Radosti C, Salyers KL, Seefeld MA, Smyth MG, Takata DT, Uzinskas IN, Vaidya K, Wallis NG, Winram SB, Yuan CC, Huffman WF.

Antimicrob Agents Chemother. 2002 Oct;46(10):3118-24.

7.

Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.

Li X, Hilgers M, Cunningham M, Chen Z, Trzoss M, Zhang J, Kohnen L, Lam T, Creighton C, G C K, Nelson K, Kwan B, Stidham M, Brown-Driver V, Shaw KJ, Finn J.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5171-6. doi: 10.1016/j.bmcl.2011.07.059. Epub 2011 Jul 23.

PMID:
21831637
8.

Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents.

Kung PP, Casper MD, Cook KL, Wilson-Lingardo L, Risen LM, Vickers TA, Ranken R, Blyn LB, Wyatt JR, Cook PD, Ecker DJ.

J Med Chem. 1999 Nov 4;42(22):4705-13.

PMID:
10579832
9.

Antibacterial effect of some 2,6-disubstituted 4-anilinoquinazolines.

Gottasová R, Kubíková J, Cipák L.

Folia Microbiol (Praha). 1998;43(6):679-82.

PMID:
10189231
10.

Antibacterial effects of trisubstituted quinazoline derivatives.

Jantová S, Greif G, Spirková K, Stankovský S, Oravcová M.

Folia Microbiol (Praha). 2000;45(2):133-7.

PMID:
11271820
11.

Bis-phosphonium salts of pyridoxine: the relationship between structure and antibacterial activity.

Pugachev MV, Shtyrlin NV, Sapozhnikov SV, Sysoeva LP, Iksanova AG, Nikitina EV, Musin RZ, Lodochnikova OA, Berdnikov EA, Shtyrlin YG.

Bioorg Med Chem. 2013 Dec 1;21(23):7330-42. doi: 10.1016/j.bmc.2013.09.056. Epub 2013 Oct 1.

PMID:
24139168
12.

Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1997 Aug 22;46(33):765-6. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Sep 12;46(36):851.

13.

Identification of antimicrobial compounds active against intracellular Staphylococcus aureus.

Malouin F, Brouillette E, Martinez A, Boyll BJ, Toth JL, Gage JL, Allen NE.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):245-52.

14.

Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).

Song MX, Zheng CJ, Deng XQ, Sun LP, Wu Y, Hong L, Li YJ, Liu Y, Wei ZY, Jin MJ, Piao HR.

Eur J Med Chem. 2013 Feb;60:376-85. doi: 10.1016/j.ejmech.2012.12.007. Epub 2012 Dec 20.

PMID:
23314051
15.

Antimicrobial activity of some substituted triazoloquinazolines.

Jantová S, Ovádeková R, Letasiová S, Spirková K, Stankovský S.

Folia Microbiol (Praha). 2005;50(2):90-4.

PMID:
16110909
16.

DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.

Kaizerman JA, Gross MI, Ge Y, White S, Hu W, Duan JX, Baird EE, Johnson KW, Tanaka RD, Moser HE, Bürli RW.

J Med Chem. 2003 Aug 28;46(18):3914-29.

PMID:
12930152
17.

Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines.

Ma X, Tan ST, Khoo CL, Sim HM, Chan LW, Chui WK.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5428-31. doi: 10.1016/j.bmcl.2011.06.125. Epub 2011 Jul 2.

PMID:
21788136
18.

The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model.

Nagl M, Hengster P, Semenitz E, Gottardi W.

J Antimicrob Chemother. 1999 Jun;43(6):805-9.

19.

Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus.

Ghorab MM, Ismail ZH, Abdalla M, Radwan AA.

Arch Pharm Res. 2013 Jun;36(6):660-70. doi: 10.1007/s12272-013-0094-6.

PMID:
23529860
20.

Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.

Shao C, Zhou W, Zhang S, Wei W, Ruan L, Jin Y, Sun X, Huang Y.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6732-8. doi: 10.1016/j.bmcl.2011.09.045. Epub 2011 Sep 18.

PMID:
21978682
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk